<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinical studies in humans strongly support a link between <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and non-ischemic <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The occurrence of a specific insulin resistant <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, independent of <z:hpo ids='HP_0002597'>vascular abnormalities</z:hpo>, is now recognized </plain></SENT>
<SENT sid="2" pm="."><plain>The progression of cardiac pathology linked with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is poorly understood </plain></SENT>
<SENT sid="3" pm="."><plain>Cardiac <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is characterized by reduced availability of sarcolemmal Glut4 transporters and consequent lower <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake </plain></SENT>
<SENT sid="4" pm="."><plain>A shift away from glycolysis towards fatty acid oxidation for ATP supply is apparent and is associated with myocardial <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Reliance of cardiomyocyte excitation-contraction coupling on glycolytically-derived ATP supply potentially renders cardiac function vulnerable to the metabolic remodelling adaptations observed in <z:mp ids='MP_0002055'>diabetes</z:mp> development </plain></SENT>
<SENT sid="6" pm="."><plain>Findings from Glut4KO mice demonstrate that cardiomyocytes with extreme <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake deficiency exhibit <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and marked excitation-contraction coupling abnormalities characterized by reduced sarcolemmal <z:chebi fb="0" ids="29108">Ca2+</z:chebi> influx and sarcoplasmic reticulum <z:chebi fb="0" ids="29108">Ca2+</z:chebi> uptake </plain></SENT>
<SENT sid="7" pm="."><plain>The 'milder' phenotype <z:chebi fb="15" ids="28757">fructose</z:chebi>-fed mouse model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> does not show evidence of <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> but cardiomyocyte loss linked with autophagic activation is evident </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="15" ids="28757">Fructose</z:chebi> feeding induces a dramatic reduction in intracellular <z:chebi fb="0" ids="29108">Ca2+</z:chebi> availability with myofilament adaptation to preserve contractile function in this setting </plain></SENT>
<SENT sid="9" pm="."><plain>The cardiac metabolic adaptations of two load-independent models of <z:mp ids='MP_0002055'>diabetes</z:mp>, the Glut4 deficient mouse, and the <z:chebi fb="15" ids="28757">fructose</z:chebi>-fed mouse are contrasted </plain></SENT>
<SENT sid="10" pm="."><plain>The role of autophagy in diabetic cardiopathology is evaluated and anomalies of type 1 vs type 2 diabetic autophagic responses are highlighted. © 2012 The Authors Clinical and Experimental Pharmacology and <z:mp ids='MP_0001532'>Physiology</z:mp> © 2012 Blackwell Publishing Asia Pty Ltd </plain></SENT>
</text></document>